BIOMAT Database Logo BIOMAT Database Logo

Impact of calcimimetics in surgery of secondary hyperparathyroidism. 2017

José Ruiz, and Antonio Ríos, and José Manuel Rodríguez, and Santiago Llorente, and Antonio Miguel Hernández, and Pascual Parrilla
Departamento de Cirugía, Ginecología, Obstetricia y Pediatría, Universidad de Murcia, Murcia, España; Servicio de Cirugía General y del Aparato Digestivo, Hospital Clínico Universitario Virgen de la Arrixaca, Servicio Murciano de Salud, El Palmar, Murcia, España.

UI MeSH Term Description Entries
D006962 Hyperparathyroidism, Secondary Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY. Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069449 Cinacalcet AMG 073,AMG073,Alpha-methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphaR)-hydrochloride,Cinacalcet Hydrochloride,KRN 1493,Sensipar
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

José Ruiz, and Antonio Ríos, and José Manuel Rodríguez, and Santiago Llorente, and Antonio Miguel Hernández, and Pascual Parrilla
[Oral calcimimetics on secondary hyperparathyroidism of uremia.]
January 2017, Clinical calcium,
José Ruiz, and Antonio Ríos, and José Manuel Rodríguez, and Santiago Llorente, and Antonio Miguel Hernández, and Pascual Parrilla
[Parenteral calcimimetics for the treatment of secondary hyperparathyroidism.]
January 2017, Clinical calcium,
José Ruiz, and Antonio Ríos, and José Manuel Rodríguez, and Santiago Llorente, and Antonio Miguel Hernández, and Pascual Parrilla
Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics.
October 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
José Ruiz, and Antonio Ríos, and José Manuel Rodríguez, and Santiago Llorente, and Antonio Miguel Hernández, and Pascual Parrilla
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
January 2014, The Cochrane database of systematic reviews,
José Ruiz, and Antonio Ríos, and José Manuel Rodríguez, and Santiago Llorente, and Antonio Miguel Hernández, and Pascual Parrilla
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
October 2006, The Cochrane database of systematic reviews,
José Ruiz, and Antonio Ríos, and José Manuel Rodríguez, and Santiago Llorente, and Antonio Miguel Hernández, and Pascual Parrilla
[Basic and clinical aspects of calcimimetics. Treatment of secondary hyperparathyroidism in dialysis patients with calcimimetics].
January 2008, Clinical calcium,
José Ruiz, and Antonio Ríos, and José Manuel Rodríguez, and Santiago Llorente, and Antonio Miguel Hernández, and Pascual Parrilla
Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism.
January 2017, Annals of surgical oncology,
José Ruiz, and Antonio Ríos, and José Manuel Rodríguez, and Santiago Llorente, and Antonio Miguel Hernández, and Pascual Parrilla
[Progress in the treatment of secondary hyperparathyroidism. Role of calcimimetics].
January 2006, Przeglad lekarski,
José Ruiz, and Antonio Ríos, and José Manuel Rodríguez, and Santiago Llorente, and Antonio Miguel Hernández, and Pascual Parrilla
Calcimimetics and the treatment of primary and secondary hyperparathyroidism.
November 2004, The Annals of pharmacotherapy,
José Ruiz, and Antonio Ríos, and José Manuel Rodríguez, and Santiago Llorente, and Antonio Miguel Hernández, and Pascual Parrilla
[Calcimimetics: no competition for surgery in primary hyperparathyroidism].
April 2012, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
Copied contents to your clipboard!